European Medicines Agency (EMA) | News and press releases Follow New medicine for two types of pulmonary fibrosis EMA has recommended granting a marketing authorisation in the European Union (EU) for Jascayd (nerandomilast) to treat adults with idiopathic pulmonary fibrosis (IPF) or… https://www.ema.europa.eu/en/news/new-medicine-two-types-pulmonary-fibrosis ema.europa.eu
